Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 435
  • Home
  • Print this page
  • Email this page
REVIEW ARTICLE
Year : 2017  |  Volume : 4  |  Issue : 4  |  Page : 323-329

Role of systemic antibiotics in preventing epidermal growth factor receptor: Tyrosine kinase inhibitors-induced skin toxicities


1 Directorate of Nursing, Sultan Qaboos University Hospital, Muscat, Oman
2 Department of Medicine, Sultan Qaboos University Hospital, Muscat, Oman

Correspondence Address:
Philomena Charlotte Dsouza
C/O Nursing Directorate, Sultan Qaboos University Hospital, Muscat
Oman
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/apjon.apjon_28_17

Rights and Permissions

The epidermal growth factor receptor (EGFR) is actively involved in the growth of multiple tumor types and has been found as an effective treatment target in various solid cancers, for example, lung cancer and head and neck cancer. Of effective drugs which target and inhibit EGFR functions, tyrosine kinase inhibitors have shown promising results, albeit at a cost of side effects, skin toxicity being the most common. This article provides an evidence-based strategy to oncology nurse practitioners in dealing with such toxicity.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed2148    
    Printed57    
    Emailed0    
    PDF Downloaded233    
    Comments [Add]    
    Cited by others 1    

Recommend this journal